MabVax Therapeutics Holdings, Inc.(Other OTC/NBB : MBVX)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | 0.75% | 82.27 | 0.7% | $1554.99m | |
| JNJ | Johnson & Johnson | 1.03% | 165.77 | 0.7% | $1044.61m | |
| PFE | Pfizer Inc. | 0.90% | 43.54 | 0.9% | $941.96m | |
| ABBV | AbbVie, Inc. | 0.84% | 109.41 | 1.9% | $659.88m | |
| LLY | Eli Lilly & Co. | 1.40% | 248.48 | 1.1% | $639.12m | |
| BMY | Bristol-Myers Squibb Co. | 0.69% | 58.21 | 1.0% | $634.93m | |
| AZN | AstraZeneca Plc | 0.79% | 62.26 | 1.0% | $284.98m | |
| NVS | Novartis AG | 1.76% | 84.83 | 0.2% | $182.69m | |
| GSK | GlaxoSmithKline Plc | 0.88% | 40.16 | 0.2% | $165.27m | |
| AVIR | Atea Pharmaceuticals, Inc. | -2.59% | 12.39 | 0.3% | $123.47m | |
| RGEN | Repligen Corp. | -0.31% | 273.83 | 6.8% | $109.24m | |
| NVO | Novo Nordisk A/S | 1.14% | 107.38 | 0.1% | $90.85m | |
| VTRS | Viatris, Inc. | -2.32% | 13.48 | 0.0% | $89.53m | |
| SNY | Sanofi | 0.34% | 49.96 | 0.2% | $66.44m | |
| OGN | Organon & Co. | -0.46% | 36.74 | 0.0% | $53.17m |
Company Profile
MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.